Johnson & Johnson announced it has reached a $20.4 million settlement with two Ohio counties ahead of a huge federal trial to determine responsibility for the opioid crisis, The Washington Post reports.
The proposed settlement with OxyContin maker Purdue Pharma is “no more than a stopgap for local and state governments,” which will continue to face costs related to the opioid crisis that far exceed the agreed upon amounts, according to a new report by Moody’s Investors Services.
OxyContin maker Purdue Pharma has reached a tentative settlement worth billions of dollars to resolve thousands of lawsuits brought by state and local governments who sued the drug company for its role in the opioid epidemic.
Opioid-related death rates between 2006 and 2012 were highest in rural communities in West Virginia, Kentucky and Virginia with a disproportionate share of opioid painkiller prescriptions, according to an analysis by The Washington Post.
On the second day of trial of a lawsuit against drug company Johnson & Johnson, the father of a college football player who died of an opioid overdose gave emotional testimony about the personal impact of the opioid crisis, Reuters reports.
Some people who can no longer “doctor shop” to get multiple prescriptions for opioid painkillers because of stricter regulations are still able to get the drugs from relatives with prescriptions, a new study suggests.
The opioid epidemic has put enormous strain on our nation’s state courts, many of which have been overwhelmed by growing dockets and shrinking resources, leaders from the National Judicial Opioid Task Force explain.
The Justice Department on Wednesday announced 53 medical professionals and seven other individuals have been charged in connection with allegedly illegally prescribing and distributing opioids and other dangerous narcotics.
Lawsuits filed by the attorneys general in Massachusetts and New York have brought to light the extensive involvement of the Sackler family, which owns OxyContin maker Purdue Pharma, in the opioid crisis, The New York Times reports.
Purdue Pharma, which makes OxyContin, has agreed to pay $270 million to resolve a lawsuit filed by Oklahoma’s attorney general, The Wall Street Journal reports. The majority of the settlement will fund a national opioid addiction center.
Teens prescribed opioids after surgery are almost twice as likely to use the drugs long-term if they have a family member who has filled opioid prescriptions for four months or more over the past year, a new study finds.